Lobbying Filing Details

Total Spending

$260,000

Activities

8

Lobbyists

4

Gov't Entities

19

Filing Information
Filing UUID:
a7cfd4c5-e449-4307-a737-5cf9459174d6
Type:
Q2 - 2nd Quarter - Report
Period:
2024 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 22, 2024 at 11:38 PM
Income:
$0
Expenses:
$260,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Paul T. Doucette
Registrant
BATTELLE MEMORIAL INSTITUTE
Columbus, Ohio
Client
BATTELLE MEMORIAL INSTITUTE
Ohio, United States of America
Lobbying Activities (8)
Activity 1
Budget/Appropriations

HR 8997; Draft Senate Bill; Energy and Water Development and Related Agencies Appropriations Bill, 2025; Title III, Department of Energy, all provisions and issues relating to the Department of Energy, and its science, energy, and national security programs. H.R. 9026; Draft Senate Bill; Commerce, Justice, Science and Related Agencies Appropriations Bill, 2025; National Science Foundation, Research and Related Activities; FBI, provisions related to biodefense lab operations. H.R. 8774; Draft Senate Bill; Defense Appropriations Bill, 2025; Issues and provisions related to Title II - O&M; Title III - Procurement; Title IV - RDT&E, Title VI - Defense Health, and the Military and National Intelligence programs. H.R. 8752; Draft Senate Bill; Department of Homeland Security Appropriations Bill, 2025; Science and Technology Directorate, all issues related to laboratory facilities, and research, development, acquisition, and operations; issues related to BioWatch and BD21; issues related to chemical and biological readiness. TSA Security Equipment Maintenance. Countering Weapons of Mass Destruction Office, issues related to biological defense; USCG O&M. H.R. 9029; Draft Senate Bill; Labor, HHS Appropriations Bill 2025; Issues related to HHS; pandemic preparedness, vaccines; CDC, gene synthesis screening. H.R. 8998; Draft Senate Bill; Interior & Environment Appropriations Bill 2025; Issues related to PFAS destruction and destruction verification methods. Issues related to the Administration's Fiscal Year 2025 budget request for the Department of Energy and its science, energy, environmental management, and national security programs. Issues related to implementation of the CHIPS and Science Act. Issues related to vaccines, genomic sequencing; medical countermeasures, pandemic preparedness and response. Issues related to infrastructure spending: PFAS remediation; I-ARPA. Issues related to Biosecurity.

Lobbyists (4)
  • MRS. MARY M TOLER
  • MR. PAUL TIMOTHY DOUCETTE
  • JEFFREY J. ROSE
  • MRS. HEATHER HESCHELES GAGNE
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Energy, Dept of
Activity 2
Defense

H.R. 8070; S. 4638; National Defense Authorization Act for Fiscal Year 2025; Issues and provisions related to Title II - O&M; Title III - Procurement; Title IV - RDT&E, Title VI - Defense Health, the Military and National Intelligence programs and environmental restoration and PFAS destruction Technology. Issues related to Senate provision on Price Anderson Act H.R. 8512; S. 4443; Intelligence Authorization Act for FY25; Intelligence Activities including cyber, microelectronics, biotechnology, biopreparedness, biosecurity and intelligence matters relating to China Draft Bills; Defense Appropriations Bill, 2025; Issues and provisions related to Title II - O&M; Title III - Procurement; Title IV - RDT&E, Title VI - Defense Health, and the Military and National Intelligence programs. S. 3799; PREVENT Pandemics Act; Biosecurity; Biopreparedness; Biotechnology; Congressionally Directed Medical Research Program; Spinal Cord Injury Research Program; Neurotechnology S. 3558; H.R. 7085; A bill to prohibit contracting with certain biotechnology providers, and for other purposes.; All titles and sections. Issues related to NNSA weapons and nonproliferation programs. Issues related to Semiconductor / Microelectronics Manufacturing and Research; implementation of CHIPS and Science Act. Issues related to military health and rehabilitation; veteran rehabilitation; neurotechnology. Issues related to Biosecurity.

Lobbyists (4)
  • MRS. MARY M TOLER
  • MR. PAUL TIMOTHY DOUCETTE
  • JEFFREY J. ROSE
  • MRS. HEATHER HESCHELES GAGNE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Energy/Nuclear

Draft Bill and rules; Hydrogen and Fuel Cell R&D; Issues related to DOE Hydrogen R&D programs and roll out. H.R. 6544; Atomic Energy Advancement Act; Issues related to Price Anderson Reauthorization. Rules; Hydrogen 45V; Issue related to Hydrogen tax credit. S. 1111; ADVANCE Act of 2023; Issues related to Price Anderson Reauthorization. Issues related to Department of Energy Office of Fossil Energy Issues related to Department of Energy technology transfer and commercialization policies and activities. Issues related to smart grid, energy storage and electricity cybersecurity funding, programs, facilities and initiatives. Issues related to nuclear infrastructure and advanced reactor technologies and fuels. Issues related to biological and environmental research, and climate programs and laboratories. Issues related to DOE's renewable energy, energy efficiency, nuclear energy and fossil energy R&D programs. Issues related to the Administration's Fiscal Year 2024 and 2025 budget request for the Department of Energy and its science, energy, environmental management, and national security programs. Issues related to national laboratory facilities and infrastructure funding, financing, and operations. Issues related to R&D in support of cleanup and nuclear security missions. Issues related to DOE Environmental Management Programs. Issues related to Price Anderson Reauthorization. Issues related to research security.

Lobbyists (3)
  • MRS. MARY M TOLER
  • MR. PAUL TIMOTHY DOUCETTE
  • JEFFREY J. ROSE
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Energy, Dept of
Activity 4
Environment/Superfund

Draft bill; PFAS Authorization bill; Authorization bill to address PFAS issues. H.R. 8998; Draft Senate Bill; Interior & Environment Appropriations bill for FY25; Issues Related to PFAS destruction and destruction verification methods.

Lobbyists (2)
  • JEFFREY J. ROSE
  • MRS. HEATHER HESCHELES GAGNE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 5
Health Issues

S. 3799 (117th); Implementation of "PREVENT Pandemics" Act; Issues related to pandemic prevention; testing; surveillance. H.R. 9029; Draft Senate Bill; Labor, HHS Appropriations Bill 2025; Issues related to HHS; pandemic preparedness, vaccines; gene synthesis screening; CDC. Draft Bills; Pandemic All Hazardous Prevent Act (PAHPA); Issues related to MCM PRV; Gene Synthesis Screening. Draft Bills; Securing Gene Synthesis Act; Issues related to gene synthesis products and screening S. 3558; H.R. 7085; A bill to prohibit contracting with certain biotechnology providers, and for other purposes.; All titles and sections. Issues related to COVID-19 testing and vaccine studies; Vaccine durability and efficacy; genomic sequencing; medical countermeasures; autoinjectors; pandemic preparedness and response. Issues related to CDC authorization and appropriations;Consensus Based Entity. Issues related to military health and rehabilitation (neurotechnology).

Lobbyists (2)
  • JEFFREY J. ROSE
  • MRS. HEATHER HESCHELES GAGNE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 6
Homeland Security

H.R. 8752, Draft Senate Bill; Department of Homeland Security Appropriations Bill, 2025; Issues related to DHS Science and Technology Directorate chem-bio defense mission and laboratory operations, research, and infrastructure; TSA TSL and Procurement, Construction and Improvements; Countering Weapons of Mass Destruction Office issues related to R&D and biodefense; Biowatch and BD21 programs S.1210, H.R. 2791; National Biodefense Analysis and Countermeasures Center Authorization Act of 2023; All titles and sections. S. 3558; H.R. 7085; A bill to prohibit contracting with certain biotechnology providers, and for other purposes.; All titles and sections. Issues related to CWMD; BD21. Issues related to DHS S&T Directorate. Issues related to laboratory facilities and infrastructure.

Lobbyists (3)
  • MR. PAUL TIMOTHY DOUCETTE
  • JEFFREY J. ROSE
  • MRS. HEATHER HESCHELES GAGNE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 7
Intelligence

H.R. 8512; S.4443; Intelligence Authorization Act for FY25; Intelligence Activities including cyber, microelectronics, biotechnology, biopreparedness, biosecurity, and intelligence matters relating to China.

Lobbyists (2)
  • MR. PAUL TIMOTHY DOUCETTE
  • MRS. HEATHER HESCHELES GAGNE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 8
Science/Technology

Issues related to the Department of Energy Office of Science funding, programs, facilities, and initiatives. Issues related to nuclear physics research and facilities and isotope production. Issues related to Department of Energy technology transfer and commercialization policies and activities. Issues related to federal funding for basic scientific research. Issues related to Department of Energy supercomputing, quantum information sciences. Issues related to artificial intelligence/machine learning. Issues related to fusion energy research and international collaborations. Issues related to national laboratory facilities and infrastructure funding, financing, and operations. Issues related to biomanufacturing; biosecurity; biopreparedness. Issues related to Neurotechnology. Issues related to NSF; R&D and Innovation investments. Issues related to Semiconductor / Microelectronic manufuacturing and research. Issues related to research security. Issues related to implementation of the CHIPS and Science Act.

Lobbyists (4)
  • MRS. MARY M TOLER
  • MR. PAUL TIMOTHY DOUCETTE
  • JEFFREY J. ROSE
  • MRS. HEATHER HESCHELES GAGNE
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Energy, Dept of

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.